Cargando…

R13 preserves motor performance in SOD1(G93A) mice by improving mitochondrial function

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by death of motor neurons in the brain and spinal cord. However, so far, there is no effective treatment for ALS. Methods: In this study, R13, a prodrug of 7,8-dihydroxyflavone, selectively activating tyrosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiao, Chen, Chongyang, Zhan, Xu, Li, Binyao, Zhang, Zaijun, Li, Shupeng, Xie, Yongmei, Song, Xiangrong, Shen, Yuanyuan, Liu, Jianjun, Liu, Ping, Liu, Gong-Ping, Yang, Xifei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210609/
https://www.ncbi.nlm.nih.gov/pubmed/34158851
http://dx.doi.org/10.7150/thno.56070
_version_ 1783709346725625856
author Li, Xiao
Chen, Chongyang
Zhan, Xu
Li, Binyao
Zhang, Zaijun
Li, Shupeng
Xie, Yongmei
Song, Xiangrong
Shen, Yuanyuan
Liu, Jianjun
Liu, Ping
Liu, Gong-Ping
Yang, Xifei
author_facet Li, Xiao
Chen, Chongyang
Zhan, Xu
Li, Binyao
Zhang, Zaijun
Li, Shupeng
Xie, Yongmei
Song, Xiangrong
Shen, Yuanyuan
Liu, Jianjun
Liu, Ping
Liu, Gong-Ping
Yang, Xifei
author_sort Li, Xiao
collection PubMed
description Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by death of motor neurons in the brain and spinal cord. However, so far, there is no effective treatment for ALS. Methods: In this study, R13, a prodrug of 7,8-dihydroxyflavone, selectively activating tyrosine kinase receptor B (TrkB) signaling pathway, was administered prophylactically to 40-day old SOD1(G93A) mice for 90 days. The motor performance was investigated by rotarod test, climbing-pole test, grip strength test and hanging endurance test. Afterwards, the spinal cord and medulla oblongata of 130-day old mice were harvested, and the proteomics revealed the effect of R13 on mouse protein expression profile. Astrocytes and microglial proliferation were assessed by immunohistochemical analysis. The number of motor neurons in the spinal cord is determined by Nissl staining. The effect of R13 on gastrocnemius morphology was assessed by HE staining. The effect of R13 on the survival rate was accomplished with worms stably expressing G93A SOD1. Results: Behavioral tests showed that R13 significantly attenuated abnormal motor performance of SOD1(G93A) mice. R13 reduced the advance of spinal motor neuron pathology and gastrocnemius muscle atrophy. The proliferation of microglia and astrocytes was reduced by R13 treatment. Mitochondriomics analysis revealed that R13 modified the mitochondrial protein expression profiles in the medulla oblongata and spinal cord of SOD1(G93A) mice, particularly promoting the expression of proteins related to oxidative phosphorylation (OXPHOS). Further study found that R13 activated AMPK/PGC-1α/Nrf1/Tfam, promoted mitochondrial biogenesis and ameliorated mitochondrial dysfunction. Lastly, R13 prolonged the survival rate of worms stably expressing G93A SOD1. Conclusions: These findings suggest oral R13 treatment slowed the advance of motor system disease in a reliable animal model of ALS, supporting that R13 might be useful for treating ALS.
format Online
Article
Text
id pubmed-8210609
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-82106092021-06-21 R13 preserves motor performance in SOD1(G93A) mice by improving mitochondrial function Li, Xiao Chen, Chongyang Zhan, Xu Li, Binyao Zhang, Zaijun Li, Shupeng Xie, Yongmei Song, Xiangrong Shen, Yuanyuan Liu, Jianjun Liu, Ping Liu, Gong-Ping Yang, Xifei Theranostics Research Paper Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by death of motor neurons in the brain and spinal cord. However, so far, there is no effective treatment for ALS. Methods: In this study, R13, a prodrug of 7,8-dihydroxyflavone, selectively activating tyrosine kinase receptor B (TrkB) signaling pathway, was administered prophylactically to 40-day old SOD1(G93A) mice for 90 days. The motor performance was investigated by rotarod test, climbing-pole test, grip strength test and hanging endurance test. Afterwards, the spinal cord and medulla oblongata of 130-day old mice were harvested, and the proteomics revealed the effect of R13 on mouse protein expression profile. Astrocytes and microglial proliferation were assessed by immunohistochemical analysis. The number of motor neurons in the spinal cord is determined by Nissl staining. The effect of R13 on gastrocnemius morphology was assessed by HE staining. The effect of R13 on the survival rate was accomplished with worms stably expressing G93A SOD1. Results: Behavioral tests showed that R13 significantly attenuated abnormal motor performance of SOD1(G93A) mice. R13 reduced the advance of spinal motor neuron pathology and gastrocnemius muscle atrophy. The proliferation of microglia and astrocytes was reduced by R13 treatment. Mitochondriomics analysis revealed that R13 modified the mitochondrial protein expression profiles in the medulla oblongata and spinal cord of SOD1(G93A) mice, particularly promoting the expression of proteins related to oxidative phosphorylation (OXPHOS). Further study found that R13 activated AMPK/PGC-1α/Nrf1/Tfam, promoted mitochondrial biogenesis and ameliorated mitochondrial dysfunction. Lastly, R13 prolonged the survival rate of worms stably expressing G93A SOD1. Conclusions: These findings suggest oral R13 treatment slowed the advance of motor system disease in a reliable animal model of ALS, supporting that R13 might be useful for treating ALS. Ivyspring International Publisher 2021-05-24 /pmc/articles/PMC8210609/ /pubmed/34158851 http://dx.doi.org/10.7150/thno.56070 Text en © The author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Li, Xiao
Chen, Chongyang
Zhan, Xu
Li, Binyao
Zhang, Zaijun
Li, Shupeng
Xie, Yongmei
Song, Xiangrong
Shen, Yuanyuan
Liu, Jianjun
Liu, Ping
Liu, Gong-Ping
Yang, Xifei
R13 preserves motor performance in SOD1(G93A) mice by improving mitochondrial function
title R13 preserves motor performance in SOD1(G93A) mice by improving mitochondrial function
title_full R13 preserves motor performance in SOD1(G93A) mice by improving mitochondrial function
title_fullStr R13 preserves motor performance in SOD1(G93A) mice by improving mitochondrial function
title_full_unstemmed R13 preserves motor performance in SOD1(G93A) mice by improving mitochondrial function
title_short R13 preserves motor performance in SOD1(G93A) mice by improving mitochondrial function
title_sort r13 preserves motor performance in sod1(g93a) mice by improving mitochondrial function
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210609/
https://www.ncbi.nlm.nih.gov/pubmed/34158851
http://dx.doi.org/10.7150/thno.56070
work_keys_str_mv AT lixiao r13preservesmotorperformanceinsod1g93amicebyimprovingmitochondrialfunction
AT chenchongyang r13preservesmotorperformanceinsod1g93amicebyimprovingmitochondrialfunction
AT zhanxu r13preservesmotorperformanceinsod1g93amicebyimprovingmitochondrialfunction
AT libinyao r13preservesmotorperformanceinsod1g93amicebyimprovingmitochondrialfunction
AT zhangzaijun r13preservesmotorperformanceinsod1g93amicebyimprovingmitochondrialfunction
AT lishupeng r13preservesmotorperformanceinsod1g93amicebyimprovingmitochondrialfunction
AT xieyongmei r13preservesmotorperformanceinsod1g93amicebyimprovingmitochondrialfunction
AT songxiangrong r13preservesmotorperformanceinsod1g93amicebyimprovingmitochondrialfunction
AT shenyuanyuan r13preservesmotorperformanceinsod1g93amicebyimprovingmitochondrialfunction
AT liujianjun r13preservesmotorperformanceinsod1g93amicebyimprovingmitochondrialfunction
AT liuping r13preservesmotorperformanceinsod1g93amicebyimprovingmitochondrialfunction
AT liugongping r13preservesmotorperformanceinsod1g93amicebyimprovingmitochondrialfunction
AT yangxifei r13preservesmotorperformanceinsod1g93amicebyimprovingmitochondrialfunction